SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-055590
Filing Date
2024-05-08
Accepted
2024-05-08 16:01:44
Documents
68
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q scyx-20240331.htm   iXBRL 10-Q 1518995
2 EX-10.1 scyx-ex10_1.htm EX-10.1 153338
3 EX-10.2 scyx-ex10_2.htm EX-10.2 10144
4 EX-31.1 scyx-ex31_1.htm EX-31.1 16289
5 EX-31.2 scyx-ex31_2.htm EX-31.2 16797
6 EX-32.1 scyx-ex32_1.htm EX-32.1 10587
  Complete submission text file 0000950170-24-055590.txt   8404634

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT scyx-20240331.xsd EX-101.SCH 1161382
71 EXTRACTED XBRL INSTANCE DOCUMENT scyx-20240331_htm.xml XML 1761582
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

IRS No.: 562181648 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36365 | Film No.: 24925733
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)